Adrian Senderowicz - 16 Jun 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: Director
Signature: /s/ Adrian Senderowicz
Issuer symbol: PBYI
Transactions as of: 16 Jun 2022
Transactions value $: -$73,303
Form type: 4
Filing time: 21 Jun 2022, 21:55:01
Previous filing: 17 Jun 2022
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Sale	-$73.3K	-27.9K	-50.78%	$2.63	27K	16 Jun 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

These shares were sold pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.